Manipulation of the gut-liver axis by interruption of bile acid recirculation: an option for the treatment of sclerosing cholangitis?

Gut. 2018 Sep;67(9):1565-1567. doi: 10.1136/gutjnl-2018-316375. Epub 2018 Apr 20.

Authors

Daniel Jahn¹, Marco Marzioni², Andreas Geier¹

Affiliations

¹ Division of Hepatology, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
² Clinic of Gastroenterology and Hepatology, Università Politecnica delle Marche, Ospedali Riuniti University Hospital, Ancona, Italy.

PMID: 29678931
DOI: 10.1136/gutjnl-2018-316375

No abstract available

Keywords: bile acid; cholestatic liver diseases; glucagen-like peptides; primary sclerosing cholangitis.

Publication types

Comment

MeSH terms

Bile Acids and Salts
Cholangitis, Sclerosing*
Humans
Liver*

Substances

Bile Acids and Salts